Humacyte Inc

NASDAQ:HUMA  
5.48
+0.37 (+7.24%)
Earnings Announcements

Humacyte Reports Q4 Results

Published: 03/29/2022 11:23 GMT
Humacyte Inc (HUMA) - Q4 Revenue $177,000.
Qtrly Earnings per Share $0.41.
Q4 Earnings per Share View $-0.21, Revenue View $254000.00 -- Refinitiv Ibes Data (analyst estimates).
Cash, Cash Equivalents and Short-term Investments of $225.5 Million As of December 31, 2021, Compared to $39.9 Million As of December 31, 2020.
Believes That Cash, Cash Equivalents and Short-term Investments Are Adequate to Fund Operations Through End of 2024.
Revenue is expected to be $0.24 Million
Adjusted EPS is expected to be -$0.22

Next Quarter Revenue Guidance is expected to be $0.24 Million
Next Quarter EPS Guidance is expected to be -$0.23

More details on our Analysts Page.